Skip to content
ClinCalc Pro
Menu
Chemical Cautery — Epistaxis

Silver Nitrate

Brand names: Silver Nitrate Sticks (AVOCA 95%)

Silver nitrate is a chemical cautery agent applied topically in ENT practice, most commonly to a discrete anterior nasal septal bleeding point (Little's area) to control or prevent recurrent epistaxis.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

On contact with moist mucosa it releases silver ions that precipitate tissue proteins, producing a controlled coagulative chemical burn that seals superficial bleeding vessels.

Prescribing in practice

  • Cauterise only one side of the septum at any single sitting and avoid cauterising both sides opposite each other, as bilateral septal cautery risks septal perforation.
  • Apply to a clean, topically anaesthetised, accessible anterior bleeding point under direct vision; it is unsuitable for posterior or briskly active bleeds where the source cannot be seen.
  • Limit the contact area and duration to the visible vessel, as excess application causes unnecessary mucosal injury and can leave grey-black argyric staining.

Monitoring

No systemic monitoring is required; review for re-bleeding, septal healing and any persistent crusting or discomfort at follow-up.

Counselling the patient

  • Expect a temporary grey or black mark and mild stinging at the treated spot.
  • Avoid nose-picking, forceful blowing and nasal trauma while it heals.
  • Use any prescribed nasal moisturiser and seek review if bleeding recurs.

Evidence & guidelines

Chemical cautery of Little's area is an established first-line measure for recurrent anterior epistaxis in UK ENT and emergency practice.

Reference: ENT-UK Epistaxis Guidelines 2016; NICE CKS Epistaxis; Gifford and Edkins (Classic epistaxis anatomy); Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.